secwatch.observer — SEC 8-K summary
======================================

Issuer:     CalciMedica, Inc. (CALC)
CIK:        0001534133
Form:       8-K
Filed at:   2024-11-08T23:59:59+00:00
Accession:  0001193125-24-253754
Event type: leadership
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CalciMedica appoints Stephen Bardin as CFO; Dan Geffken resigns as interim CFO
------------------------------------------------------------------------------

- Dan Geffken resigned as interim CFO effective after filing Q3 2024 10-Q.
- Stephen Bardin appointed CFO, principal financial and accounting officer; previously a consultant since April 2024.
- Bardin served as CFO of ATAI Life Sciences (2022-2024) and SVP Finance at BridgeBio (2022).
- Compensation: $380k base salary, $20k signing bonus, 100k stock option and 40k RSUs granted.
- Option vests 25% on Oct 1, 2025 then monthly; RSUs vest 25% on Oct 1, 2025 then quarterly.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534133/000119312524253754/0001193125-24-253754-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534133/000119312524253754/d862451d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-24-253754

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer